Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Price to Cash Earnings (PCE)

    Back to All Ratios
AARTI PHARMALABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   PCE(x) 19.1418.8813.599.72-

What is the latest Price to Cash Earnings (PCE) ratio of AARTI PHARMALABS ?

The latest Price to Cash Earnings (PCE) ratio of AARTI PHARMALABS is 19.14 based on Mar2026 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202619.14
Mar202518.88
Mar202413.59
Mar20239.72
Mar2022-

How is Price to Cash Earnings (PCE) of AARTI PHARMALABS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2026 19.14
1.38
Mar2025 18.88
38.93
Mar2024 13.59
39.81
Mar2023 9.72
0
Mar2022 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Price to Cash Earnings (PCE) ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹7,446.9 Cr -6.2% -7.1% -3.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr -1.7% -10.2% 30.5% Stock Analytics
CIPLA ₹108,012.0 Cr 0.9% -3.2% -15.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr -0.6% 1% -0.1% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-6.2%

-7.1%

-3.1%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses